These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24251644)

  • 1. Polypharmacy reduction in youth in a residential treatment center leads to positive treatment outcomes and significant cost savings.
    van Wattum PJ; Fabius C; Roos C; Smith C; Johnson T
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):620-7. PubMed ID: 24251644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medication management in a residential group care program.
    Spellman DF; Griffith AK; Huefner JC; Wise N; McElderry E; Leslie LK
    Child Welfare; 2010; 89(2):151-67. PubMed ID: 20857885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naturalistic study of medication reduction in a residential treatment setting.
    Connor DF; McLaughlin TJ
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):302-10. PubMed ID: 15910214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: a prospective analysis of admission, discharge, and 6-month follow-up medication costs.
    Cunningham JL; Rome JD; Kerkvliet JL; Townsend CO
    Pain Med; 2009; 10(5):787-96. PubMed ID: 19302437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of abuse and gender on psychopathology, behavioral disturbance, and psychotropic medication count for youth in residential treatment.
    Badura Brack A; Huefner JC; Handwerk ML
    Am J Orthopsychiatry; 2012 Oct; 82(4):562-72. PubMed ID: 23039354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility.
    Procyshyn RM; Su J; Elbe D; Liu AY; Panenka WJ; Davidson J; Honer WG; Barr AM
    J Clin Psychopharmacol; 2014 Feb; 34(1):17-22. PubMed ID: 24346744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
    Fontanella CA; Bridge JA; Campo JV
    Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic medication utilization in a child and adolescent mental health service.
    Dean AJ; McDermott BM; Marshall RT
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):273-85. PubMed ID: 16768635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic prescription practices in child psychiatric inpatients 9 years old and younger.
    Lekhwani M; Nair C; Nikhinson I; Ambrosini PJ
    J Child Adolesc Psychopharmacol; 2004; 14(1):95-103. PubMed ID: 15142396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
    Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
    Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Psychiatric Practice Guidelines on Medication Costs and Youth Aggression in a Juvenile Justice Residential Treatment Program.
    Lee TG; Walker SC; Bishop AS
    Psychiatr Serv; 2016 Feb; 67(2):214-20. PubMed ID: 26423102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality.
    Mansur N; Weiss A; Beloosesky Y
    Ann Pharmacother; 2008 Jun; 42(6):783-9. PubMed ID: 18445704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care.
    Oerbeck B; Overgaard KR; Hjellvik V; Lien L; Bramness JG
    J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):350-357. PubMed ID: 33635152
    [No Abstract]   [Full Text] [Related]  

  • 20. The economic cost of using restraint and the value added by restraint reduction or elimination.
    Lebel J; Goldstein R
    Psychiatr Serv; 2005 Sep; 56(9):1109-14. PubMed ID: 16148326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.